medical devices
medical devices
HTA and Value-Based Healthcare: Methods
March 4, 2021
9:00 a.m. MST
Panelists:
Richard Charter, Vice-President, Alira Health
Iga Lipska, Research Project Manager at National Health Fund
Anastasia Chalkidou, Associate Director and Senior Research Fellow in HTA
Joseph Casey, Professor, Director of Partnerships and Programme Session Details
This session will discuss the methodological differences between HTA and Value-Based Healthcare and how they can be applied to Medical Devices. The aim is to provide participants with a comprehensive understanding of how HTA and VBHC methods can be used in practice. It will further the goals and mission of the Medical Devices Interest Group, including advancing the dialogue on Medical Device HTA methods and evidence-based policy-making to develop the way we evaluate a rapidly evolving technology sector.
HTA and Value-Based Healthcare: Methods
March 25, 2021
8:00 a.m. MDT
Panelists:
Richard Charter, Vice-President, Alira Health
Andrea Rappagliosi, Vice President Market Access, Public Affairs & Communication EMEA, Canada and LATAM Edwards Lifesciences
Joseph Casey – Director of Partnerships and Programme
Session Details:
This session will build on the methods discussed in the first session through a series of case studies. Using real-life experiences, the speakers will distinguish the roles of HTA and Value-Based Healthcare in the evaluation and implementation of medical technologies and discuss value-based access programs (managed entry agreements). This session aims to give participants an understanding of how to implement the different methods in practice and will discuss how they complement each other in a rapidly evolving MedTech landscape.
HTA and Value-Based Healthcare: Methods
March 4, 2021
9:00 a.m. MST
Panelists:
Richard Charter, Vice-President, Alira Health
Iga Lipska, Research Project Manager at National Health Fund
Anastasia Chalkidou, Associate Director and Senior Research Fellow in HTA
Joseph Casey, Professor, Director of Partnerships and Programme Session Details
This session will discuss the methodological differences between HTA and Value-Based Healthcare and how they can be applied to Medical Devices. The aim is to provide participants with a comprehensive understanding of how HTA and VBHC methods can be used in practice. It will further the goals and mission of the Medical Devices Interest Group, including advancing the dialogue on Medical Device HTA methods and evidence-based policy-making to develop the way we evaluate a rapidly evolving technology sector.
HTA and Value-Based Healthcare: Methods
March 25, 2021
8:00 a.m. MDT
Panelists:
Richard Charter, Vice-President, Alira Health
Andrea Rappagliosi, Vice President Market Access, Public Affairs & Communication EMEA, Canada and LATAM Edwards Lifesciences
Joseph Casey – Director of Partnerships and Programme
Session Details:
This session will build on the methods discussed in the first session through a series of case studies. Using real-life experiences, the speakers will distinguish the roles of HTA and Value-Based Healthcare in the evaluation and implementation of medical technologies and discuss value-based access programs (managed entry agreements). This session aims to give participants an understanding of how to implement the different methods in practice and will discuss how they complement each other in a rapidly evolving MedTech landscape.
MDIG ORGANIZATIONAL INFORMATION
Co-Chair: Richard Charter, Switzerland
Co-Chair: Anastasia, Chalkidou, United Kingdom
Technical Officer: Jarno Suominen, Finland